... brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers ...
http://www.pmpnews.com/news/mylan-launches-generic-nor-qd-tablets-035-mg-28-day-cycle
http://www.pmpnews.com/news/mylan-launches-generic-nor-qd-tablets-035-mg-28-day-cycle
No comments:
Post a Comment